CAMECO CORPORATION (CCJ): what the price assumes

In the published model solve dated 2026-Q2, anchored at $100.00, CAMECO CORPORATION (CCJ) is priced for today's economics sustained for ~20.4 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/CCJ

Headline

FieldValue
TickerCCJ
CompanyCAMECO CORPORATION
Sector / IndustryBasic Materials
Current price$100.00/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Must persist for20.4y
Multiple paid93x operating income

Solve inputs: computed at a 11.6% cost of capital; growth searched up to the 25% self-funding ceiling.

How unusual the bet is: n/a

ReferenceValue
vs own history-0.46σ

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset9.67x5expensive
Earnings4.65x3expensive
Relative7.05x5expensive
Growth2.07x3expensive

Families that call it expensive: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.3%); the inversion above states its own rate.

Per-Model Detail (n=16)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$48.362.07xyesFCF base $0.8B, growth 24% (input: historical growth), terminal g 4.0%, WACC 9.3%, 5yr projection
DCF Exit MultipleGrowth$89.241.12xyesExit EV/EBITDA: 58.8x / 63.8x / 68.8x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$32.813.05xyesP/E 30.8x (blended: static sector reference 14x + trailing (TTM) 100x), scenarios: 23.1x / 30.8x / 37.0x (bear / base = reference held flat / bull), EV/EBITDA 17.6x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$10.769.29xyesBV/sh $11.66, ROE (TTM) 8.5%, ke 9.3%
Two-Stage Excess ReturnAsset$10.349.67xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$36.692.73xyesRev $2.6B, growth 24% (input: historical growth; tapered), Terminal P/S: 4.5x / 6.0x / 7.2x (bear / base = today's held flat / bull, cap 6x)
Peter Lynch Fair ValueRelative$11.918.40xyesEPS $0.99, growth 2% (input: historical EPS growth), PEG=62.05 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$4.5122.17xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.19B × (1−24%) / WACC 9.3% → EPV (no growth) (excluded from median)
Residual IncomeAsset$10.279.74xyesBV $11.66 + 5yr PV of (ROE (TTM) 8.5% − Kₑ 9.3%) × BV; BV grows 5.6%/yr
Graham NumberAsset$16.146.20xyes√(22.5 × EPS $0.99 × BVPS $11.66) — Graham's conservative floor
EV/EBITDA RelativeRelative$14.197.05xyesEBITDA $0.67B × sector EV/EBITDA 8.0x
FCF YieldEarnings$21.514.65xyesFCF $790.7M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$32.033.12xyesEPS $0.99 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$10.219.79xyesBV $11.66 × (ROIC 8.1% / WACC 9.3%)
P/Sales SectorRelative$8.8211.34xyesRevenue $2.56B × sector P/S 1.5x
PEG Fair ValueRelative$37.222.69xyesEPS $0.99 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$10.739.32xyesEPS $0.99 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$85.5m
Net debt / NOPAT (after-tax)-0.25x (net cash)
Net debt / operating income (pre-tax)-0.19x (net cash)
Interest coverage11.8x
Share count CAGR (dilution)2.3%
Burning cashno

Bullet Takeaways

Bull Case

Two production interruptions in a single quarter, and the outlook did not move. McArthur River and Key Lake returned to full production at the end of May after flooding, with 2026 guidance left unchanged. Cigar Lake went down on July 1 when Orano's McClean Lake mill, which processes its ore, ran into difficulty, and was producing again on July 14. Both were plumbing problems in the broadest sense: water in one case, a processing bottleneck in the other. Neither was a problem with the rock.

That distinction carries further in uranium than in most commodities, because the supply that would answer a high price is slow, permitted, and frequently contingent on somebody else's money. Centrus, the American enricher, ties new capacity at its Ohio plant to work that will "depend on our ability to secure substantial public and private investment necessary to build new enrichment capacity". The same filing notes that "The LEU segment backlog also includes approximately $0.1 billion of deferred revenue and advances from customers as of December 31, 2025", and that "No orders in our backlog are considered at risk, in material respect, related to customer operations." Utilities are paying ahead for fuel they will not take delivery of for years. That is what a tight fuel market looks like from the customer's side of the desk.

The mining side of the field is thinner still. UEC describes itself as "the largest licensed uranium producer in the U.S.", and reports that its restarted Christensen Ranch operation "yielded 103,545 pounds and 26,421 pounds of precipitated uranium and dried and drummed concentrate, respectively" during fiscal 2025. Read that twice. The largest licensed American producer measured a ramp year's output in the low hundreds of thousands of pounds. Whatever the uranium price does, the queue of people able to respond to it in size is short, and the response takes years.

Cameco converts its position in that queue into cash without waiting for the next spot print. Free cash flow ran at 790.7 million dollars on revenue of 2.56 billion dollars, and the interest bill is covered about 11.8 times over. The net position on the balance sheet is barely positive, which sounds unimpressive until you notice that it does not need to be more than that: the business funds itself, is not burning cash, and does not require the market's permission to keep operating through a soft patch.

None of this makes the price cheap, and the bull case is weaker when it pretends otherwise. What it makes the business is durable, and durable is the precondition for everything the price is paying for. Long-lived assets, customers who prepay, and competitors whose expansion plans read like grant applications are a genuinely unusual combination. The bull argument is that the combination persists long enough to matter, not that it is currently being given away.

Bear Case

Run Cameco's price past every conventional way of valuing a mining company and not one of them reaches it. Against the asset-value methods, which price the balance sheet and the returns earned on it, the price sits about eight and a half times their central estimate. Against the earnings-power methods, which capitalize what the business earned across a full cycle and credit no growth whatsoever, it sits roughly six times above theirs. The peer-multiple methods land in the same territory. Only the forward-growth methods reach anywhere near the quote, and the nearest of them manages it by holding the cash-flow multiple fixed at its present level all the way through the projection, so that five years of compounding does the entire job. That is the assumption restated, not tested.

Invert the price and the demand it makes is about duration rather than pace. At roughly 83 times company-wide operating profit, discounted at 11.5%, the quote implies operating growth pinned at the ceiling the business can fund out of its own cash flow for something close to 19 years. The rate is not the stretch. Cameco has delivered that rate recently. The length is the stretch, and of comparable fast growers only about 15% held such a pace even ten years. That solve is a single pass under fixed assumptions and deserves to be read as a direction rather than a measurement, but the direction is not subtle. Each percentage point of growth is worth roughly 2.7 years of runway, which is another way of saying the answer moves a long way on inputs nobody can observe.

Then there is what mining is. Peak earnings and sustainable earnings are different numbers in this sector, and the gap between them is widest at the moment the cycle looks most convincing. NEM's filing states the structural version plainly: "as current resources are depleted, exploration and advanced projects are necessary for us to replace the depleting reserves or enhance the recovery and processing of the current reserves to sustain production at existing operations". Reserves are a melting asset. Replacing them costs money that never appears as growth, and the cost of replacing them rises as the easy ground is used up. July supplied the near-term version of the same fragility: the mine was fine and it stopped anyway, because the mill that processes its ore belongs to a partner.

Holders have also been paying for part of this growth without seeing the invoice. The share count has compounded at about 2.3% a year since the end of 2021, so a slice of what reads as growth per share is simply growth divided among more shares. Set against that, the downside is not unbounded. The company holds about 2.1 billion dollars of equity stakes outside the operating business, roughly 5.5% of its market value, and those sit where they are whatever uranium does. It is a floor. It is a small one next to the distance between the price and everything the standard methods can defend.

Valuation

Begin with the multiple, because it frames the rest. At $87.82, the market is paying about 83 times company-wide operating profit for a cyclical miner. Inverted, that price reads as a bet on duration: operating growth held at the ceiling the business can self-fund, sustained for roughly 19 years, discounted at 11.5%. The record rates the reliability of that solve as low, so it is best treated as a direction of travel rather than a measurement. What it establishes without ambiguity is that very little of today's price is being paid for today's earnings.

The methods used to triangulate the price all point the same way, which is itself uncommon. Asset value, earnings power, peer multiples and forward growth each land below $87.82, so no family of method defends the quote on its own terms. The distances are wide. The price sits about eight and a half times above the asset-value central estimate and roughly six times above both the earnings-power and the peer-multiple ones. The forward-growth family is nearest, a little under twice its central estimate, and it gets there by projecting revenue and cash flow forward at the recent growth rate rather than a long-run one, then declining to compress the multiple at the end.

Cohort comparison is awkward for this name, because the pure-play uranium companies are far smaller and the large miners in the comparison set dig up different things. The scale contrast is still instructive. LEU, the enricher, runs 452.3 million dollars of revenue at a 6.7% operating margin. HCC turns 1.469 billion dollars of revenue into a 9.7% operating margin and grew 11.1% on the year. Further up the size curve, SCCO reports a 54.6% operating margin and FCX 27.8%, both on revenue many times Cameco's. Nothing in that spread explains the premium in Cameco's price. The premium is being paid for what the market expects the uranium market itself to do.

The balance sheet neither rescues the case nor endangers it. Gross debt runs about 702.3 million dollars against liquid assets a little above that, so the net position is barely positive, and the interest bill is covered about 11.8 times over. The company is not burning cash. What that balance sheet cannot do is shorten the wait: it will carry the business through a weak stretch in the uranium price, but it does nothing to secure the two decades of compounding the quote is written against, and the share count has been drifting up 2.3% a year in the meantime. Solvency is not what this price is risking. The length of the runway is.

Catalysts

The next scheduled information event is close. Cameco confirmed that second-quarter 2026 results will be issued on July 31, 2026 before market open. That print matters more than a routine quarter would, because it is the first full accounting of a period that contained two separate production interruptions. Management left annual guidance unchanged when first-quarter results were published on May 5, 2026, and unchanged again when operations were restored later that month.

On the operating side, McArthur River and Key Lake resumed full production at the end of May following flooding, with 2026 guidance held. Cigar Lake then suspended production on July 1, 2026 because of difficulties at Orano's McClean Lake mill, where Cigar Lake ore is processed, and resumed activity on July 14, 2026. Separately, the purchase of TEPCO Resources Inc.'s 5% interest in the Cigar Lake joint venture closed on July 2, 2026, lifting the combined ownership held by Cameco and Orano.

The demand side has been supplying its own headlines. In late June the company welcomed a US Department of Energy conditional commitment under the American Nuclear Supply Chain Loans program, aimed at accelerating AP1000 reactor deployment. Reactor construction decisions are the slowest-moving input into a uranium producer's order book and the most durable once made, so policy steps of this kind read through to contracting years before they read through to revenue.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Cameco news releases, July 1 and July 14, 2026 · Cameco news releases, July 17 and May 27, 2026 · Cameco news release, May 27, 2026 · Cameco news release, July 1, 2026 · Cameco news release, July 17, 2026 · Cameco news releases, May 5 and May 27, 2026 · Cameco news release, July 2, 2026 · Cameco news release, June 23, 2026

View the full interactive CCJ report on boothcheck